CCA Medical Research Corp

Ajax, Ontario L1S 7K8

0 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, Moderate Psoriasis, Plaque Psoriasis, Prurigo Nodularis, Psoriasis, Psoriasis (PsO), Severe Psoriasis

Studies at this site

• A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 — Completed
• A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis — Stopped early
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis — Running, not enrolling